Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News St Jude Medical launches new spinal cord stimulation trials

St Jude Medical launches new spinal cord stimulation trials

6th December 2013

St Jude Medical has announced the launch of two new clinical studies that will broaden understanding of the wider uses of spinal cord stimulation therapy.

The first of these studies will involve the Prodigy neurostimulator, the first spinal cord stimulation system able to deliver a proprietary mode of stimulation therapy called burst stimulation. It aims to assess whether burst stimulation can be more effective in managing chronic pain than traditional tonic stimulation.

It is thought that this technique can provider paresthesia-free pain relief, making it useful for patients who cannot tolerate or have failed to benefit from traditional stimulation.

Meanwhile, the second study will evaluate a combination of peripheral nerve field stimulation and spinal cord stimulation, in order to judge whether the two therapies together offer more effective management of chronic low back and leg pain than spinal cord stimulation alone.

Dr Mark Carlson, chief medical officer and vice-president of global clinical affairs for St Jude Medical, said: "Traditional spinal cord stimulation therapy has been used to manage chronic pain for more than 40 years and it works very well for many pain conditions."ADNFCR-8000103-ID-801669675-ADNFCR

We currently have 5 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.